Loading…
Cardio Diagnostics Holdings, Inc. is projected to decline to $1.70 by 2027, a -7% move from its current price of $1.83. CDIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.76 | $1.83 | $1.90 | +0.01% |
| Jul 13 | $1.73 | $1.83 | $1.93 | +0.03% |
| Jul 14 | $1.71 | $1.83 | $1.96 | +0.04% |
| Jul 15 | $1.70 | $1.83 | $1.98 | +0.06% |
| Jul 16 | $1.68 | $1.83 | $2.00 | +0.07% |
| Jul 17 | $1.67 | $1.83 | $2.01 | +0.09% |
| Jul 18 | $1.65 | $1.83 | $2.03 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.65 | $1.83 | $2.03 | +0.10% |
| Week 2 | $1.59 | $1.83 | $2.12 | +0.21% |
| Week 3 | $1.54 | $1.84 | $2.19 | +0.31% |
| Week 4 | $1.50 | $1.84 | $2.25 | +0.41% |
| Week 5 | $1.46 | $1.84 | $2.31 | +0.52% |
| Week 6 | $1.43 | $1.84 | $2.36 | +0.62% |
| Week 7 | $1.41 | $1.84 | $2.41 | +0.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease.
It also provides Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations.
Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings, Inc. (CDIO) is a healthcare company focused on epigenetics-based cardiovascular tests. The stock has a current price of $1.85 and a market cap of $5.48M, with a rank of 5301.
A major floor 25.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.5% away) — a key level to hold.
The nearest ceiling, 28.4% above — a clean break opens room to run.
A major ceiling 193.4% above — clearing it would confirm fresh momentum.
Key CDIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.90 | Sell | $1.90 | Sell |
| MA 10 | $1.99 | Sell | $1.95 | Sell |
| MA 20 | $2.00 | Sell | $1.97 | Sell |
| MA 50 | $1.89 | Sell | $1.99 | Sell |
| MA 100 | $2.36 | Sell | $2.22 | Sell |
| MA 200 | $2.74 | Sell | $3.28 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.04 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -169.19 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -16.82 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 20.56 | Buy |
| Momentum (10) | -0.19 | Sell |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 1.82 | Buy |
| ADX (14) | 10.85 | Neutral |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bearish. RSI14 is 40, and the price has a nearby resistance at $2.35 with a support at $1.75. The moving averages show SMA50 at $1.88 and SMA200 at $2.75. The thirty-day range runs from $1.42 to $2.40, and annualized volatility is 80%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.05 | $1.83 | $2.50 | 0% | Neutral | |
| $1.30 | $1.70 | $2.38 | -7% | Neutral | |
| $1.52 | $2.07 | $3.04 | +13% | Neutral | |
| $1.76 | $2.47 | $3.78 | +35% | Bullish | |
| $1.62 | $2.35 | $3.71 | +29% | Bullish | |
| $1.60 | $2.39 | $3.87 | +31% | Bullish | |
| $1.39 | $2.13 | $3.53 | +16% | Neutral | |
| $1.30 | $2.05 | $3.48 | +12% | Neutral | |
| $1.68 | $2.71 | $4.70 | +48% | Bullish | |
| $1.75 | $2.89 | $5.09 | +58% | Bullish | |
| $1.77 | $3.25 | $6.21 | +78% | Bullish | |
| $2.57 | $5.72 | $12.19 | +212% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.05 | $1.83 | $2.28 | +0.00% |
| August 2026 | $1.59 | $1.89 | $2.34 | +3.49% |
| September 2026 | $1.54 | $1.85 | $2.32 | -2.06% |
| October 2026 | $1.60 | $1.94 | $2.46 | +4.64% |
| November 2026 | $1.64 | $2.01 | $2.58 | +3.74% |
| December 2026 | $1.56 | $1.93 | $2.50 | -4.16% |
Click any year to see its month-by-month CDIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Cardio Diagnostics Holdings, Inc.'s 2026 outlook centres on $1.83, within a $1.05 to $2.50 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, CDIO could reach as high as $2.38, with a base case around $1.70 and support toward $1.30 — roughly -7% from $1.83. A consolidation phase looks the most probable path here.
Expect CDIO to range from $1.52 to $3.04 through 2028. The $2.07 average target implies a +13% move from current prices. That is up +21% on the projected 2027 average. Price action looks broadly range-bound.
The CDIO price prediction for 2029 points to an average of $2.47 (low $1.76, high $3.78) — a potential gain of +35% on today's $1.83. Buyers look set to stay in control over this stretch.
In 2030, CDIO is projected to trade between $1.62 and $3.71, averaging $2.35 — a potential gain of +29% from today's $1.83. That is -5% versus the projected 2029 average. Momentum favours further upside here.
Cardio Diagnostics Holdings, Inc.'s 2031 outlook centres on $2.39, within a $1.60 to $3.87 range. That is up +2% on the projected 2030 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, CDIO could reach as high as $3.53, with a base case around $2.13 and support toward $1.39 — roughly +16% from $1.83. Price action looks broadly range-bound.
Expect CDIO to range from $1.30 to $3.48 through 2033. The $2.05 average target implies a +12% move from current prices. That is -4% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The CDIO price prediction for 2034 points to an average of $2.71 (low $1.68, high $4.70) — a potential gain of +48% on today's $1.83. Momentum favours further upside here.
In 2035, CDIO is projected to trade between $1.75 and $5.09, averaging $2.89 — a potential gain of +58% from today's $1.83. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Cardio Diagnostics Holdings, Inc.'s 2040 outlook centres on $3.25, within a $1.77 to $6.21 range. That is up +13% on the projected 2035 average. That marks a +78% change versus current levels. Momentum favours further upside here.
By 2050, CDIO could reach as high as $12.19, with a base case around $5.72 and support toward $2.57 — roughly +212% from $1.83. Buyers look set to stay in control over this stretch.
Investing $1,000 in CDIO today (≈ 546.448087 CDIO) could be worth
$3,124.29
+$2,124.29 (+212%) by 2050 · US Dollar
Based on the average projected CDIO price of $5.72 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDIOwould be worth at today's price.
$1,000 invested in CDIO on Jul 10, 2025 (≈ 233.100235 CDIO) would be worth
$426.57
-$573.43 (-57.3%) today · 0.43× · US Dollar
Based on a CDIO entry price of $4.29 vs. today's $1.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.99 | $919.6 | -8.0% |
| 1 month ago | $1.93 | $948.19 | -5.2% |
| 3 months ago | $1.83 | $1,000 | -0.0% |
| 6 months ago | $1.94 | $943.3 | -5.7% |
| 1 year ago | $4.29 | $426.57 | -57.3% |
| All time (4.5y) ago | $294.6 | $6.21 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDIO forecast.
Our base-case forecast reaches $3.70 around 2050.
Implied market cap at $3.70: $10.95M
The multi-year forecast shows a bullish trajectory after a muted start. For 2026 the average price is $1.85 with a min of $1.05 and a max of $2.53, a neutral sentiment and 0% ROI. By 2029 the average is $2.52 with a 36% ROI and a bullish sentiment.
2030 projects an average of $2.39 with a max of $3.80 and a 29.2% ROI, continuing with bullish sentiment. In 2040 the average is $3.30 with a max of $6.37 and a 78.2% ROI, and by 2050 the average is $5.78 with a max of $12.51 and a 212.7% ROI, still bullish. These figures illustrate potential upside over time, but they are estimates and not guarantees.
Tap a question to reveal the answer.
The forecast shows an average price of $2.39 with a min of $1.63 and a max of $3.80, a 29.2% ROI, and bullish sentiment.
Forecasts indicate mixed sentiment in early years (neutral in 2026 and 2027) but bullish from 2029 onward, with 2029 avg $2.52 and 36% ROI, 2030 avg $2.39 and 29.2% ROI, and a 2050 max of $12.51 with 212.7% ROI.
Yes. The 2050 max forecast is $12.51, which exceeds $10.
The current price is $1.85 and the market cap is $5.48M.
Bearish sentiment with RSI14 at 40; SMA50 at $1.88 and SMA200 at $2.75; support at $1.75 and resistance at $2.35. The thirty-day range is $1.42–$2.40 and annualized volatility is 80%.
Cardio Diagnostics Holdings, Inc. Community Discussion
0Share your Cardio Diagnostics Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.